Drug & medication recalls Moderate risk

Guaiatussin AC Sugar-Free recalled over manufacturing violations

Recall date
April 26, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Akorn, Inc. recalls Guaiatussin AC Sugar-Free, Each teaspoonful (5 mL) contains: Guaifenesin (100 mg), Codeine Phosphate (10 mg), Alcohol (…
Recall number
D-0807-2023
FDA classification
Class II
Brand / firm
Akorn, Inc.
Sold / distributed
Nationwide in the USA and Puerto Rico

Why it was recalled

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Guaiatussin AC Sugar-Free, Each teaspoonful (5 mL) contains: Guaifenesin (100 mg), Codeine Phosphate (10 mg), Alcohol (3.5% v/v), a) packaged in a) 118 mL bottles, b) 473 mL bottles and c) 100 unit dose cups, Rx Only, Distributed by: Akorn, Inc., Lake Forest, IL 60045. ALL NDCs

Get recall alerts

Free email alert whenever Akorn, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Akorn, Inc.